Menu Search
Equities

Global Hemp Group Inc

GBHPF:PKC

Global Hemp Group Inc

Actions
  • Price (USD)0.06
  • Today's Change0.00 / 0.00%
  • Shares traded4.20k
  • 1 Year change-55.22%
  • Beta--
Data delayed at least 15 minutes, as of May 03 2024 18:44 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Global Hemp Group Inc. is a Canada-based company, which is focused on developing and promoting hemp-based products. The Company operates through two segments: BioPharma Division and Industrial Hemp Division. BioPharma Division has executed a Letter of Intent (LOI) with B-Organic R&D Corp. (B-Organic) to license its Bioactive Lipid Agents (BLA) technology, a patented matrix, which is able to increase the solubility and bioavailability of various poorly soluble pharma ingredients, including cannabinoids. Industrial Hemp Division is involved in the development and promotion of hemp-based products. The Company’s has acquired the perpetual license for North America (the United States, Canada and Mexico) to certain Apollon Intellectual Property and proprietary technology.

  • Revenue in CAD (TTM)0.00
  • Net income in CAD-2.39m
  • Incorporated2009
  • Employees--
  • Location
    Global Hemp Group Inc#106 - 1169 Mt. Seymour RoadNORTH VANCOUVER V7H 2Y4CanadaCAN
  • Phone+1 (778) 726-2900
  • Websitehttps://globalhempgroup.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.